Kress Francois 4
4 · KYTHERA BIOPHARMACEUTICALS INC · Filed Nov 2, 2012
Insider Transaction Report
Form 4
Kress Francois
Director
Transactions
- Award
Stock Option (right to buy)
2012-10-10+5,672Exercise: $16.00Exp: 2022-10-10→ Common Stock (5,672 underlying)
Footnotes (1)
- [F1]1/3 of the shares subject to the option vest annually measured from October 10, 2012 (the "Grant Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Grant Date, subject to continued service through such date.